Stephen E. Daniels

No ORCID on file · 2 papers in corpus

rct 2002

Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea

Obstetrics & Gynecology ·doi:10.1016/s0029-7844(02)02085-9

OBJECTIVE: To compare the efficacy of the cyclooxygenase (COX)-2-specific inhibitor valdecoxib with naproxen sodium in treating menstrual pain associated with primary dysmenorrhea. METHOD: This single-center, double-blind, placebo-controll…

rct 2002

Valdecoxib, a Cyclooxygenase-2-Specific Inhibitor, Is Effective in Treating Primary Dysmenorrhea

·doi:10.1097/00006250-200208000-00025

In Brief OBJECTIVE To compare the efficacy of the cyclooxygenase (COX)-2-specific inhibitor valdecoxib with naproxen sodium in treating menstrual pain associated with primary dysmenorrhea. METHOD This single-center, double-blind, placebo-co…